title: Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
abstract: Duchenne muscular dystrophy (DMD) is a hereditary X-linked recessive disorder affecting the synthesis of dystrophin, a protein essential for structural stability in muscle. Dystrophin also occurs in the central nervous system, particularly in the neocortex, hippocampus and cerebellum. Quantitative metabolic analysis by localized (1) H MRS was performed in the cerebellum (12 patients and 15 controls) and a temporo-parietal location (eight patients and 15 controls) in patients with DMD and healthy controls to investigate possible metabolic differences. In addition, the site of individual mutations on the dystrophin gene was analyzed and neuropsychological cognitive functions were examined. Cognitive deficits in the patient group were found in line with earlier investigations, mainly concerning verbal short-term memory, visuo-spatial long-term memory and verbal fluency, but also the full-scale IQ. Causal mutations were identified in all patients with DMD. Quantitative MRS showed consistent choline deficits, in both cerebellar white matter and temporo-parietal cortex, as well as small, but significant, metabolic abnormalities for glutamate and total N-acetyl compounds in the temporo-parietal region. Compartment water analysis did not reveal any abnormalities. In healthy subjects, choline levels were age related in the cerebellum. The choline deficit contrasts with earlier findings in DMD, where a surplus of choline was postulated for the cerebellum. In patients, total N-acetyl compounds in the temporo-parietal region were related to verbal IQ and verbal short-term memory. However, choline, the putative main metabolic abnormality, was not found to be associated with cognitive deficits. Furthermore, in contrast with the cognitive performance, the metabolic brain composition did not depend significantly on whether or not gene mutations concerned the expression of the dystrophin isoform Dp140, leading to the conclusion that the effect of the missing Dp140 isoform on cognitive performance is not mediated through the observed metabolite composition, or is caused by local effects beyond the resolution accessible to MRS investigations.
authors.affiliation: Department of Clinical Research, Unit for MR-Spectroscopy & Methodology, University of Bern, Bern, Switzerland. roland.kreis@insel.ch
authors.forename: Roland
authors.initials: R
authors.lastname: Kreis
authors.forename: Kevin
authors.initials: K
authors.lastname: Wingeier
authors.forename: Peter
authors.initials: P
authors.lastname: Vermathen
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Giger
authors.forename: Franziska
authors.initials: F
authors.lastname: Joncourt
authors.forename: Karin
authors.initials: K
authors.lastname: Zwygart
authors.forename: Franz
authors.initials: F
authors.lastname: Kaufmann
authors.forename: Chris
authors.initials: C
authors.lastname: Boesch
authors.forename: Maja
authors.initials: M
authors.lastname: Steinlin
mesh_terms: D000293:Adolescent; D001921:Brain / Q000033:anatomy & histology / Q000378:metabolism*; D002648:Child; D003071:Cognition / Q000502:physiology*; D016189:Dystrophin / Q000235:genetics*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D009154:Mutation; D055815:Young Adult
chemical_list: D016189:Dystrophin